Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterium tuberculosis complex antigens refer to a diverse group of proteins and other molecules produced by members of the Mycobacterium tuberculosis complex—a clonal group of closely related mycobacterial species responsible for human and animal tuberculosis. These include both well-characterized defined proteins such as ESAT6, CFP10, Ag85 family members, HBHA (Rv0475), latency-associated DosR regulon products like Rv2031c and Rv2029c, as well as more complex mixtures derived from bacterial lysates or culture filtrates[2][5]. These antigens are recognized by the host immune system during infection and form the basis for many diagnostic tests that distinguish between latent TB infection (LTBI) and active disease. They elicit strong CD4+ T cell responses presented via HLA class II molecules—primarily HLA–DR—and are used in interferon-gamma release assays to monitor exposure or disease status[3][4]. Some serve as biomarkers for patient selection or efficacy monitoring in clinical settings. While not therapeutic targets themselves in the classical sense like enzymes or receptors targeted by small-molecule drugs, they are critical components of vaccine development efforts and diagnostic platforms. Note on correctness: The term "Mycobacterium tuberculosis complex antigens" is **not** a single molecular entity but rather an umbrella term encompassing numerous distinct protein targets from various M. tuberculosis strains/species; it is not specific enough to map directly onto one canonical molecule/receptor. For structured data purposes it should be split into its constituent defined antigenic targets where possible—such as "Early secreted antigenic target 6 kDa protein" (ESAT6), "Culture filtrate protein 10" (CFP10), etc.—to enable precise mapping. Therefore, **is_incorrect:** true — because this entry refers to a heterogeneous mixture/class rather than a unique molecular target suitable for structured annotation per your conventions.[2][5]
Induction of host immune response via T cell activation[3][4] Used in immunodiagnostic assays to detect infection or immune status[2][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium tuberculosis complex antigen.